Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones

Drug-eluting stent (DES) recipients require 6–12 months of dual antiplatelet treatment (DAPT) and long-term aspirin mono-antiplatelet treatment (MAPT). Given the diversity of contemporary antiplatelet agents, antiplatelet treatment (APT) selection is becoming more complicated. We evaluated 15-year A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sunwon, Lee, Jong-Seok, Lee, Jungkuk, Kim, Yong-Hyun, Kim, Jin-Seok, Lim, Sang-Yup, Kim, Seong Hwan, Ahn, Jeong-Cheon, Song, Woo-Hyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095404/
https://www.ncbi.nlm.nih.gov/pubmed/37048759
http://dx.doi.org/10.3390/jcm12072675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095404/
https://www.ncbi.nlm.nih.gov/pubmed/37048759
http://dx.doi.org/10.3390/jcm12072675

Ejemplares similares